NR-607 FINAL EXAM REVIEWER
150 Questions & Correct Answers | Rated 100% | Graded A+
EXAM DETAILS
| Attribute | Information |
|--|-|
| Course Code | NR-607 |
| Course Title | Psychiatric Mental Health Nurse Practitioner (PMHNP) – Advanced Practice |
| Institution | Chamberlain University / Walden University (typical) |
| Exam Type | Final Exam |
| Total Questions | 150 |
| Format | Multiple Choice, Clinical Vignettes |
| Focus Areas | Pharmacotherapy, Psychotherapy, Differential Diagnosis, Ethical/Legal Issues,
Professional Role |
| Academic Level | Graduate (MSN – PMHNP) |
SECTION 1: PHARMACOTHERAPY FOR MENTAL HEALTH DISORDERS
Questions 1–30
Question 1
First-line pharmacotherapy for Generalized Anxiety Disorder (GAD) includes:
A) Benzodiazepines
B) SSRIs (escitalopram, paroxetine, sertraline) or SNRIs (venlafaxine, duloxetine)
C) Tricyclic antidepressants
D) Buspirone only
Correct answer: B
Rationale: SSRIs and SNRIs are first-line for GAD due to their efficacy and favorable side effect
profile compared to benzodiazepines, which have dependence and withdrawal risks.
Question 2
,Which antipsychotic is most likely to cause significant weight gain and metabolic syndrome?
A) Aripiprazole
B) Ziprasidone
C) Olanzapine
D) Lurasidone
Correct answer: C
Rationale: Olanzapine has the highest risk of metabolic side effects among atypical
antipsychotics, including weight gain, diabetes, and dyslipidemia. Aripiprazole and ziprasidone
have lower metabolic risk.
Question 3
Lithium is the gold standard for treating:
A) Major depressive disorder
B) Bipolar disorder (maintenance and acute mania)
C) Generalized anxiety disorder
D) Schizophrenia
Correct answer: B
Rationale: Lithium is highly effective for acute mania and maintenance treatment of bipolar
disorder. It has anti-suicidal properties and is the most studied mood stabilizer.
Question 4
A patient on clozapine must have regular monitoring of:
A) Liver function tests
B) Absolute neutrophil count (ANC) (due to agranulocytosis risk)
C) Thyroid function tests
D) Renal function
Correct answer: B
,Rationale: Clozapine carries a black box warning for agranulocytosis (1-2% risk). ANC must be
monitored weekly for the first 6 months, then biweekly, then monthly under the REMS program.
Question 5
Serotonin syndrome is characterized by:
A) Bradycardia, constipation, sedation
B) Autonomic instability, neuromuscular excitation, altered mental status
C) Hyponatremia, weight gain, hypersomnia
D) Extrapyramidal symptoms only
Correct answer: B
Rationale: Serotonin syndrome presents with triad of autonomic instability (tachycardia,
hypertension), neuromuscular excitation (tremor, rigidity, clonus), and altered mental status
(agitation, confusion). It typically results from serotonergic polypharmacy.
Question 6
The first-line treatment for ADHD in adults is:
A) Bupropion
B) Stimulants (methylphenidate, amphetamine derivatives)
C) Atomoxetine only
D) Clonidine
Correct answer: B
Rationale: Stimulants (methylphenidate, amphetamine salts) are first-line for ADHD in adults
due to rapid onset and high efficacy. Atomoxetine and bupropion are second-line.
Question 7
Mirtazapine is particularly useful for depressed patients with:
A) Weight loss and insomnia
B) Weight gain and sedation
, C) Sexual dysfunction
D) Hypertension
Correct answer: A
Rationale: Mirtazapine is sedating at low doses and increases appetite, making it useful for
depressed patients with insomnia and weight loss. It has minimal sexual side effects.
Question 8
The FDA-approved medication for postpartum depression is:
A) Fluoxetine
B) Sertraline
C) Brexanolone (and zuranolone)
D) Venlafaxine
Correct answer: C
Rationale: Brexanolone (Zulresso) and zuranolone (Zurzuvae) are FDA-approved specifically for
postpartum depression. SSRIs are also used but not FDA-approved specifically for PPD.
Question 9
Long-acting injectable (LAI) antipsychotics are most indicated for:
A) First episode psychosis
B) Patients with poor adherence or preference for LAI
C) Acute agitation only
D) Depression with psychotic features
Correct answer: B
Rationale: LAIs are indicated for patients with recurrent hospitalizations, poor adherence, or
preference for less frequent dosing. They are effective for maintenance treatment of
schizophrenia and bipolar disorder.
Question 10
150 Questions & Correct Answers | Rated 100% | Graded A+
EXAM DETAILS
| Attribute | Information |
|--|-|
| Course Code | NR-607 |
| Course Title | Psychiatric Mental Health Nurse Practitioner (PMHNP) – Advanced Practice |
| Institution | Chamberlain University / Walden University (typical) |
| Exam Type | Final Exam |
| Total Questions | 150 |
| Format | Multiple Choice, Clinical Vignettes |
| Focus Areas | Pharmacotherapy, Psychotherapy, Differential Diagnosis, Ethical/Legal Issues,
Professional Role |
| Academic Level | Graduate (MSN – PMHNP) |
SECTION 1: PHARMACOTHERAPY FOR MENTAL HEALTH DISORDERS
Questions 1–30
Question 1
First-line pharmacotherapy for Generalized Anxiety Disorder (GAD) includes:
A) Benzodiazepines
B) SSRIs (escitalopram, paroxetine, sertraline) or SNRIs (venlafaxine, duloxetine)
C) Tricyclic antidepressants
D) Buspirone only
Correct answer: B
Rationale: SSRIs and SNRIs are first-line for GAD due to their efficacy and favorable side effect
profile compared to benzodiazepines, which have dependence and withdrawal risks.
Question 2
,Which antipsychotic is most likely to cause significant weight gain and metabolic syndrome?
A) Aripiprazole
B) Ziprasidone
C) Olanzapine
D) Lurasidone
Correct answer: C
Rationale: Olanzapine has the highest risk of metabolic side effects among atypical
antipsychotics, including weight gain, diabetes, and dyslipidemia. Aripiprazole and ziprasidone
have lower metabolic risk.
Question 3
Lithium is the gold standard for treating:
A) Major depressive disorder
B) Bipolar disorder (maintenance and acute mania)
C) Generalized anxiety disorder
D) Schizophrenia
Correct answer: B
Rationale: Lithium is highly effective for acute mania and maintenance treatment of bipolar
disorder. It has anti-suicidal properties and is the most studied mood stabilizer.
Question 4
A patient on clozapine must have regular monitoring of:
A) Liver function tests
B) Absolute neutrophil count (ANC) (due to agranulocytosis risk)
C) Thyroid function tests
D) Renal function
Correct answer: B
,Rationale: Clozapine carries a black box warning for agranulocytosis (1-2% risk). ANC must be
monitored weekly for the first 6 months, then biweekly, then monthly under the REMS program.
Question 5
Serotonin syndrome is characterized by:
A) Bradycardia, constipation, sedation
B) Autonomic instability, neuromuscular excitation, altered mental status
C) Hyponatremia, weight gain, hypersomnia
D) Extrapyramidal symptoms only
Correct answer: B
Rationale: Serotonin syndrome presents with triad of autonomic instability (tachycardia,
hypertension), neuromuscular excitation (tremor, rigidity, clonus), and altered mental status
(agitation, confusion). It typically results from serotonergic polypharmacy.
Question 6
The first-line treatment for ADHD in adults is:
A) Bupropion
B) Stimulants (methylphenidate, amphetamine derivatives)
C) Atomoxetine only
D) Clonidine
Correct answer: B
Rationale: Stimulants (methylphenidate, amphetamine salts) are first-line for ADHD in adults
due to rapid onset and high efficacy. Atomoxetine and bupropion are second-line.
Question 7
Mirtazapine is particularly useful for depressed patients with:
A) Weight loss and insomnia
B) Weight gain and sedation
, C) Sexual dysfunction
D) Hypertension
Correct answer: A
Rationale: Mirtazapine is sedating at low doses and increases appetite, making it useful for
depressed patients with insomnia and weight loss. It has minimal sexual side effects.
Question 8
The FDA-approved medication for postpartum depression is:
A) Fluoxetine
B) Sertraline
C) Brexanolone (and zuranolone)
D) Venlafaxine
Correct answer: C
Rationale: Brexanolone (Zulresso) and zuranolone (Zurzuvae) are FDA-approved specifically for
postpartum depression. SSRIs are also used but not FDA-approved specifically for PPD.
Question 9
Long-acting injectable (LAI) antipsychotics are most indicated for:
A) First episode psychosis
B) Patients with poor adherence or preference for LAI
C) Acute agitation only
D) Depression with psychotic features
Correct answer: B
Rationale: LAIs are indicated for patients with recurrent hospitalizations, poor adherence, or
preference for less frequent dosing. They are effective for maintenance treatment of
schizophrenia and bipolar disorder.
Question 10
